Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,008 | 3,885 | 4,947 | 11,048 | 2,338 |
| Receivables | 536 | 694 | 243 | 169 | 1,129 |
| Inventories | 3,317 | 1,747 | 1,131 | 510 | 430 |
| Other current assets | 219 | 138 | 104 | 79 | 72 |
| TOTAL | $9,147 | $6,804 | $6,878 | $12,521 | $4,278 |
| Non-Current Assets | |||||
| PPE Net | 113 | 136 | 98 | 54 | 56 |
| TOTAL | $113 | $136 | $98 | $54 | $56 |
| Total Assets | $9,260 | $6,940 | $6,976 | $12,575 | $4,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 185 | 112 | 95 | 53 | 527 |
| Accrued Expenses | 478 | 463 | 318 | 432 | 384 |
| Other current liabilities | 1,565 | 1,946 | 304 | 3,078 | 6,992 |
| TOTAL | $2,238 | $2,543 | $731 | $3,564 | $7,940 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -1,855 | -283 | 169 | 44 | 0 |
| TOTAL | $0 | $11 | $20 | $0 | $1 |
| Total Liabilities | $2,238 | $2,554 | $751 | $3,564 | $7,941 |
| Shareholders' Equity | |||||
| Retained earnings | -34,908 | -33,074 | -28,374 | -24,610 | -14,563 |
| TOTAL | $5,167 | $4,103 | $6,394 | $9,055 | $-3,607 |
| Total Liabilities And Equity | $7,405 | $6,657 | $7,145 | $12,619 | $4,334 |